Skip to content

Resuscitation Quick Actions • First 2 Minutes

High-Acuity

DO NOT Transfuse PRBCs

ABSOLUTELY CONTRAINDICATED: Transfusing red blood cells sharply increases hematocrit and whole-blood viscosity, causing fatal circulatory arrest

Hyperviscosity Classic Triad

1) Spontaneous mucosal bleeding (epistaxis/gingival), 2) Visual changes (sausage-link retinal veins), 3) Neurological deficits/confusion

Waldenström Plasmapheresis

Large IgM pentamers reside 80% intravascularly; a single session of Therapeutic Plasma Exchange (TPE) reduces viscosity by > 50%

AML Leukostasis Threshold

WBC > 50,000–100,000/mcL with high myeloblast percentage + respiratory distress (hypoxia) or neurologic deficits = STAT LEUKAPHERESIS

Cytoreductive Therapy

Hydroxyurea 2 to 4 grams PO daily (50–100 mg/kg) to rapidly reduce circulating blast counts while awaiting leukapheresis

Aggressive IV Hydration

Isotonic crystalloids at 200–250 mL/hr (without PRBCs) to hemodilute plasma and maintain microvascular capillary flow

Bottom-Line Clinical Pearl

Hyperviscosity Syndrome is a life-threatening oncologic emergency caused by an immense burden of circulating proteins or white blood cells that increases whole-blood dynamic viscosity, impeding microvascular capillary transit. (1) Paraproteinemic Hyperviscosity occurs primarily in Waldenström Macroglobulinemia (large IgM pentamers) and Multiple Myeloma. Triad: MUCOSAL BLEEDING (epistaxis, gingival), VISUAL IMPAIRMENT ('sausage-link' engorged retinal veins), and NEUROLOGIC COMPLICATIONS (confusion, somnolence, stroke). First-line therapy is EMERGENT PLASMAPHERESIS (plasma exchange). (2) Acute Leukostasis occurs in Acute Myeloid Leukemia (AML) when rigid myeloblasts exceed 50,000–100,000/mcL, plugging pulmonary and cerebral microvessels (dyspnea, diffuse infiltrates, ischemic stroke). CRITICAL CONTRAINDICATION: NEVER TRANSFUSE PACKED RED BLOOD CELLS IN HYPERVISCOSITY OR LEUKASTASIS! Even a single unit of PRBCs dramatically spikes blood viscosity, triggering fatal microvascular circulatory arrest. Administer aggressive IV hydration and prepare emergent Leukapheresis + Hydroxyurea.

1. Pathophysiology: Whole-Blood Rheology & Poiseuille's Law

Blood flow through microvascular capillary beds is governed by Poiseuille's equation, where resistance is directly proportional to blood viscosity ($\eta$). Normal serum viscosity is 1.4 to 1.8 centipoise (cP) relative to water. When dynamic viscosity exceeds 4.0 to 5.0 cP, microvascular sludging, capillary endothelial shear damage, and tissue ischemia occur throughout the central nervous system, retina, and cardiopulmonary microvasculature.

2. Clinical Presentation & Management Matrix

Condition & SubtypeCellular/Molecular EtiologyClinical Presentation & Organ FailureDefinitive Resuscitative Management
Waldenström's MacroglobulinemiaLymphoplasmacytic lymphoma producing massive amounts of monoclonal IgM pentamers (high molecular weight: 950 kDa)Hyperviscosity Triad: (1) Oozing mucosal bleeding (epistaxis, gingival), (2) Visual loss with fundoscopic 'sausage-link' engorged retinal veins and hemorrhages, (3) Encephalopathy, ataxia, somnolence, stroke. High output heart failure.Emergent Therapeutic Plasma Exchange (TPE/Plasmapheresis): Because 80% of IgM is confined to the intravascular compartment, a single 1- to 1.5-plasma-volume exchange removes $> 50\%$ of circulating paraprotein, normalizing viscosity within hours.
Multiple Myeloma (IgA or IgG)Proliferation of malignant plasma cells secreting monoclonal IgA (dimers) or IgG (requires very high concentrations $> 6\text{ to }7\text{ g/dL}$ to form aggregates)Identical hyperviscosity symptoms + CRAB criteria (Hypercalcemia, Renal failure, Anemia, Bone lytic lesions); rouleaux formation on blood smearPlasmapheresis + aggressive IV crystalloid hydration (reduces hypercalcemia and prevents Bence-Jones cast nephropathy) + Dexamethasone.
Acute Myeloid Leukemia (AML) LeukostasisUncontrolled proliferation of large, rigid, non-deformable myeloblasts; typically occurs when blast count exceeds 50,000 to 100,000/mcLLeukostatic capillary plugs: (1) Pulmonary: severe dyspnea, hypoxemia, bilateral alveolar infiltrates, respiratory arrest. (2) Neurologic: delirium, stupor, intracranial hemorrhage, coma.Emergent Leukapheresis (mechanically filters blasts) + Hydroxyurea (2–4 grams PO daily) + aggressive hydration with Rasburicase (to prevent tumor lysis syndrome).

3. Critical Emergency Pearls & Pitfalls

Critical Pitfall / Contraindication

THE DEADLY TRANSFUSION TRAP IN HYPERVISCOSITY & LEUKASTASIS: When a patient with hyperviscosity syndrome or blast crisis presents with profound fatigue and a low hemoglobin (e.g., Hb 6.5 g/dL), the reflexive administration of Packed Red Blood Cells (PRBCs) is LETHAL. Whole-blood viscosity increases exponentially with hematocrit. Infusing 1–2 units of PRBCs into a patient with high circulating paraproteins or rigid myeloblasts spikes dynamic viscosity, precipitating immediate complete microvascular capillary thrombosis, massive ischemic stroke, acute pulmonary leukostasis arrest, and death. Never transfuse until viscosity has been reduced via plasmapheresis or leukapheresis!

Board & Shelf Drill 5 Questions • Untimed Tutor Mode

Test Your Hyperviscosity Syndromes & Acute Leukostasis Clinical Acumen

Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.